Marion Dorsch - Chief Scientific Officer, Blueprint Medicines Corp

As of February 24, 2021


Marion Dorsch Net Worth

  • Net worth is estimated to be at least $7.45M
  • Owns at least 15,250 units of Blueprint Medicines Corp stock
  • Sold an estimated value of $5.84M in the last 5 years at Blueprint Medicines Corp

Marion Dorsch Trading

  • Largest purchase of shares was 18,834 units , worth over $712.59K on November 22, 2017
  • Largest sale of shares was 17,834 units , worth over $1.17M on November 22, 2017
  • In total has made about 18 transactions over 5 years
  • Usually trades in March, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Marion Dorsch Mailing Address

  • Mailing address is Blueprint Medicines Corporation 38 Sidney Street, Suite 200 Cambridge MA 02139 MA

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

Blueprint Medicines Corp Insider Trading

  • The most recent transaction was 1,950 units sold on November 18, 2021 by Ariel Hurley worth over $222.85K
  • In the last 6 years, insiders at Blueprint Medicines Corp sold an estimated value of $163.3M and bought an estimated value of $15.77M
  • The most active traders are Jeffrey Albers, CEO and President,  Ariel Hurley, Principal Accounting Officer,  and Kate Haviland, Chief Operating Officer
  • Insider trading is most common in June, with the busiest year in 2020

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1